Skip to main content
. 2021 Dec 21;31(6):468–477. doi: 10.1097/IJG.0000000000001970

TABLE 4.

Univariate Analysis for Failure

1st Baerveldt Surgery (n=76) All Baerveldt Surgeries (n=110)
Risk Factor N (%) (n=76) 5-Year Cumulative Probability Failure (%) P * HR; 95% CI N (%) (n=110) 5-Year Cumulative Probability Failure (%) P * HR; 95% CI
Sex 0.39 0.55
 Male 41 (54) 39 0.73; 0.34–1.54 52 (47) 37 0.83; 0.45–1.56
 Female 35 (46) 37 58 (53) 41
Age (y) 0.17 0.009
 0-5 37 (49) 43 0.38; 0.15–0.99 53 (48) 45 0.25; 0.11–0.55
 6-10 16 (21) 20 2.80; 0.90–8.70 25 (23) 13 5.05; 1.95–13.08
 11+ 23 (30) 49 1.23; 0.54–2.97§ 32 (29) 56 1.48; 0.73–3.01§
Ethnicity 0.20 0.14
 Caucasian 52 (68) 31 1.62; 0.76–3.76 74 (67) 35 1.59; 0.82–3.09
 Non-Caucasian 24 (32) 47 36 (33) 47
Prior glaucoma surgeries 0.18 0.01
 None 31 (41) 28 1.69; 0.80–3.55 46 (42) 25 2.41; 1.29–4.49
 1 or more 45 (59) 45 64 (58) 49
Preoperative IOP (mm Hg) 0.14 0.53
 0-20 24 (32) 55 0.42; 0.18–1.01 29 (26) 52 0.70; 0.33–1.46
 21-30 29 (38) 31 0.78; 0.28–2.18 48 (44) 36 0.92; 0.42–2.04
 31+ 23 (30) 28 0.57; 0.24–1.37# 33 (30) 29 0.66; 0.29–1.47#
Preoperative medications 0.44 0.55
 0-2 22 (29) 47 0.71; 0.30–1.68 31 (28) 49 0.82; 0.40–1.66
 3+ 54 (71) 35 79 (72) 36
Procedure 0.45 0.79
 Single procedure 62 (82) 39 1.57; 0.57–4.33 88 (79) 39 1.12; 0.51–2.46
 Staged procedure 14 (18) 43 23 (21) 40
Concurrent procedure 0.45 0.76
 Yes 37 (49) 41 0.75; 0.36–1.58 54 (49) 39 0.91; 0.49–1.69
 No 39 (51) 33 56 (51) 38
Type of glaucoma 0.32 0.32
 Primary 21 (28) 30 1.48; 0.64–3.40 34 (31) 34 1.38; 0.70–2.70
 Secondary 55 (72) 41 76 (69) 41

Statistically significant P<0.05 values are in bold.

*

P-value for Log-rank (Mantel Cox) test for 2 variables or for Log-rank for trend test for 3 variables.

Age 0 to 5 versus 6 to 10.

Age 6 to 10 versus 11+.

§

Age 0 to 5 versus 11+.

IOP 0 to 20 versus 21 to 30.

IOP 21 to 30 versus 31+.

#

IOP 0 to 20 versus 31+.

CI indicates confidence interval; HR, hazard ratio; IOP, intraocular pressure.